- Home
- DARE vs LUMO Comparison
DARE vs LUMO Comparison
Compare DARE & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- LUMO
- Stock Information
- Founded
- DARE N/A
- LUMO 2011
- Country
- DARE United States
- LUMO United States
- Employees
- DARE N/A
- LUMO N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- DARE Health Care
- LUMO Health Care
- Exchange
- DARE Nasdaq
- LUMO Nasdaq
- Market Cap
- DARE 31.9M
- LUMO 37.4M
- IPO Year
- DARE N/A
- LUMO N/A
- Fundamental
- Price
- DARE $3.18
- LUMO $4.34
- Analyst Decision
- DARE Strong Buy
- LUMO Buy
- Analyst Count
- DARE 4
- LUMO 4
- Target Price
- DARE $20.33
- LUMO $9.38
- AVG Volume (30 Days)
- DARE 53.6K
- LUMO 133.0K
- Earning Date
- DARE 11-14-2024
- LUMO 11-07-2024
- Dividend Yield
- DARE N/A
- LUMO N/A
- EPS Growth
- DARE N/A
- LUMO N/A
- EPS
- DARE N/A
- LUMO N/A
- Revenue
- DARE $1,881,316.00
- LUMO $2,205,000.00
- Revenue This Year
- DARE N/A
- LUMO $184.11
- Revenue Next Year
- DARE $136.52
- LUMO N/A
- P/E Ratio
- DARE N/A
- LUMO N/A
- Revenue Growth
- DARE 88.13
- LUMO 26.94
- 52 Week Low
- DARE $3.05
- LUMO $1.37
- 52 Week High
- DARE $7.56
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- DARE 44.72
- LUMO 4.26
- Support Level
- DARE $3.18
- LUMO $4.31
- Resistance Level
- DARE $3.75
- LUMO $4.39
- Average True Range (ATR)
- DARE 0.15
- LUMO 0.03
- MACD
- DARE 0.01
- LUMO -0.44
- Stochastic Oscillator
- DARE 8.77
- LUMO 0.00
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.